Triple

T1151207
Position Surface form Disambiguated ID Type / Status
Subject International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E23680 entity
Predicate notableWork P4 FINISHED
Object ICH E6 Good Clinical Practice
ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
E131969 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ICH E6 Good Clinical Practice | Statement: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, notableWork, ICH E6 Good Clinical Practice]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: ICH E6 Good Clinical Practice
Context triple: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, notableWork, ICH E6 Good Clinical Practice]
  • A. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • B. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
    The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
  • C. ISO 14971
    ISO 14971 is an international standard that specifies a systematic process for risk management of medical devices throughout their life cycle.
  • D. GAC Principles and Guidelines
    GAC Principles and Guidelines are a set of policy frameworks and best-practice recommendations developed to guide governments’ participation and advice on public policy issues related to the global Domain Name System within ICANN.
  • E. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: ICH E6 Good Clinical Practice
Triple: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, notableWork, ICH E6 Good Clinical Practice]
Generated description
ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: ICH E6 Good Clinical Practice
Target entity description: ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
  • A. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • B. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
    The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
  • C. ISO 14971
    ISO 14971 is an international standard that specifies a systematic process for risk management of medical devices throughout their life cycle.
  • D. GAC Principles and Guidelines
    GAC Principles and Guidelines are a set of policy frameworks and best-practice recommendations developed to guide governments’ participation and advice on public policy issues related to the global Domain Name System within ICANN.
  • E. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a493f0d32c8190ac74bad3c87f2641 completed March 1, 2026, 7:30 p.m.
NER Named-entity recognition batch_69a4bc744e7c81908f8612f2aad28600 completed March 1, 2026, 10:23 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac5eb5d36c8190916a43a5f41df144 completed March 7, 2026, 5:21 p.m.
NEDg Description generation batch_69ac5f4756b08190b3dbaf64a9351836 completed March 7, 2026, 5:24 p.m.
NED2 Entity disambiguation (via description) batch_69ac600f78148190bd3109276f7b9e3a completed March 7, 2026, 5:27 p.m.
Created at: March 1, 2026, 7:44 p.m.